Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The impact of recurrent urinary tract infections in women: a qualitative study.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026

Same author

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients.

JAMA network open·2026

Same author

Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).

The Lancet. Microbe·2026

Same author

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

The New England journal of medicine·2026

Same author

Association between pharmacological tenofovir adherence measures and subsequent 24-week viral load outcomes for people with HIV in South Africa.

Journal of acquired immune deficiency syndromes (1999)·2026

Same author

Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme: A randomised controlled trial (PHILA).

PLOS global public health·2026

Same journal

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026

Same journal

Tumor-versus-nonmalignant quantitative drug sensitivity profiling identifies capivasertib as a selective therapeutic candidate for nasopharyngeal carcinoma.

SLAS discovery : advancing life sciences R & D·2026

Same journal

ADCs for colorectal carcinoma: decoding clinical evidence for molecular design innovation.

SLAS discovery : advancing life sciences R & D·2026

Same journal

CellVision: A deep learning based image analysis platform to accelerate immuno-plaque assay data processing for dengue vaccine development.

SLAS discovery : advancing life sciences R & D·2026

Same journal

Use t tests to analyze counts of cells in two states.

SLAS discovery : advancing life sciences R & D·2026

Same journal

In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion.

SLAS discovery : advancing life sciences R & D·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

Published on: August 26, 2021

Bioassay protocol metadata annotation: Proposed standards adoption.

Rama Balakrishnan¹, Ellen L Berg², Christopher C Butler³

¹Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.

SLAS Discovery : Advancing Life Sciences R & D

|October 20, 2024

Summary

This summary is machine-generated.

We developed a standardized metadata template for pharmaceutical drug discovery assays to improve data understanding and computational analysis. This template, combined with an automated annotation tool, enhances the FAIRness of assay data for better drug discovery research.

Keywords:

Assay registration Bioassay Data standards Drug discovery FAIR Metadata Ontology Protocol

More Related Videos

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 10, 2025

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

Published on: August 26, 2021

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Biomedical Research
Drug Discovery
Data Science

Background:

Bioassays are critical for advancing biomedical research and drug discovery.
Increasing volumes of assay data present challenges in understanding and comparison.
Current assay data often lacks standardization, hindering computational analysis.

Purpose of the Study:

To introduce a standardized metadata template for pharmaceutical drug discovery assays.
To ensure assay data adheres to the FAIR (Findable, Accessible, Interoperable, Reusable) principles.
To facilitate the use of artificial intelligence and computational methods in drug discovery.

Main Methods:

Development of a standardized metadata template for assay data.
Utilization of an automated tool for annotating assay data.
Integration of data from diverse sources like PubChem, commercial providers, and literature.

Main Results:

A standardized metadata template for drug discovery assays has been created.
An automated tool effectively annotates assay data to the template.
The process improves the FAIRness of assay data from multiple sources.

Conclusions:

Standardized assay metadata enhances data comparability and understanding for drug discovery scientists.
Improved metadata facilitates the application of AI and computational tools for analysis and prediction.
Enhancements in assay metadata can significantly boost productivity in therapeutic and technology development.